Joanne M. Hackett - 02 Feb 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director
Signature
/s/Joanne M. Hackett
Issuer symbol
SER
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 15:50:03 UTC
Previous filing
24 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Option to Purchase Common Stock Award $0 +65,000 $0.000000 65,000 02 Feb 2022 Common Stock 65,000 $0.8336 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest and become exercisable in four equal quarterly installments on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.